|
Sessions per week (mean ± SD)
|
4 (4)
|
|
Patients per session (mean ± SD)
|
4 (3)
|
|
Number of scans per year (median ± IQR)
| |
|
• 2008
|
240 (100-730)
|
|
• 2009
|
300 (100-1000)
|
|
• 2010
|
332 (140-1200)
|
|
Inpatient waiting times
| |
|
• 24 hours
|
9 (17%)
|
|
• 48 hours
|
13 (25%)
|
|
• 2- 5 days
|
21 (40%)
|
|
• 6-10 days
|
6 (11%)
|
|
• > 10 days
|
1 (2%)
|
|
• No inpatient service
|
1 (2%)
|
|
• Unknown
|
2 (4%)
|
|
Outpatient waiting times
| |
|
• < 2 weeks
|
4 (8%)
|
|
• 2-4 weeks
|
20 (38%)
|
|
• 4-8 weeks
|
24 (45%)
|
|
• > 8 weeks
|
3 (6%)
|
|
• Unknown
|
2 (4%)
|
|
CMR funding
| |
|
Specific Funding
|
20/53 (38%)
|
|
• Primary care trust
|
11/20 (55%)
|
|
• Scottish Health Board
|
4/20 (20%)
|
|
• Tertiary
|
2/20 (10%)
|
|
• Shared primary care trust and tertiary
|
3/20 (15%)
|
|
No specific funding
|
33/53 (62%)
|
|
Indications for CMR (%)
| |
|
Coronary artery disease
|
26
|
|
• Viability
|
71
|
|
• Ischaemia
|
21
|
|
• Acute myocardial infarction
|
8
|
|
Heart failure and cardiomyopathy
|
39
|
|
Congenital heart disease
|
19
|
|
Acquired vascular diseases
|
4
|
|
Valvular heart diseases
|
4
|
|
Pericardial disease
|
4
|
|
Cardiac transplantation
|
< 1
|
|
Others (Tumours, chemotherapy)
|
4
|
